These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Biomolecular recognition of antagonists by α7 nicotinic acetylcholine receptor: Antagonistic mechanism and structure-activity relationships studies. Peng W; Ding F Eur J Pharm Sci; 2015 Aug; 76():119-32. PubMed ID: 25963024 [TBL] [Abstract][Full Text] [Related]
23. PET imaging evaluation of [(18)F]DBT-10, a novel radioligand specific to α7 nicotinic acetylcholine receptors, in nonhuman primates. Hillmer AT; Zheng MQ; Li S; Scheunemann M; Lin SF; Holden D; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Carson RE; Brust P; Huang Y Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):537-47. PubMed ID: 26455500 [TBL] [Abstract][Full Text] [Related]
24. Tropisetron sensitizes α7 containing nicotinic receptors to low levels of acetylcholine in vitro and improves memory-related task performance in young and aged animals. Callahan PM; Bertrand D; Bertrand S; Plagenhoef MR; Terry AV Neuropharmacology; 2017 May; 117():422-433. PubMed ID: 28259598 [TBL] [Abstract][Full Text] [Related]
25. Design and synthesis of new agents for neuronal nicotinic acetylcholine receptor (nAChRs) imaging. Liu Y; Yu H; Zhao L; Zhang H Nucl Med Biol; 2013 Jan; 40(1):126-34. PubMed ID: 23102538 [TBL] [Abstract][Full Text] [Related]
26. Procognitive effects of varenicline in the animal model of schizophrenia depend on α4β2- and α 7-nicotinic acetylcholine receptors. Potasiewicz A; Golebiowska J; Popik P; Nikiforuk A J Psychopharmacol; 2018 Dec; 33(1):269881118812097. PubMed ID: 30501536 [TBL] [Abstract][Full Text] [Related]
27. Methyllycaconitine: a non-radiolabeled ligand for mapping α7 neuronal nicotinic acetylcholine receptors - in vivo target localization and biodistribution in rat brain. Nirogi R; Kandikere V; Bhyrapuneni G; Saralaya R; Muddana N; Komarneni P J Pharmacol Toxicol Methods; 2012 Jul; 66(1):22-8. PubMed ID: 22609758 [TBL] [Abstract][Full Text] [Related]
28. PET imaging of α Hillmer AT; Li S; Zheng MQ; Scheunemann M; Lin SF; Nabulsi N; Holden D; Pracitto R; Labaree D; Ropchan J; Teodoro R; Deuther-Conrad W; Esterlis I; Cosgrove KP; Brust P; Carson RE; Huang Y Eur J Nucl Med Mol Imaging; 2017 Jun; 44(6):1042-1050. PubMed ID: 28120003 [TBL] [Abstract][Full Text] [Related]
29. In vivo Depiction of α7 Nicotinic Receptor Loss for Cognitive Decline in Alzheimer's Disease. Nakaizumi K; Ouchi Y; Terada T; Yoshikawa E; Kakimoto A; Isobe T; Bunai T; Yokokura M; Suzuki K; Magata Y J Alzheimers Dis; 2018; 61(4):1355-1365. PubMed ID: 29376856 [TBL] [Abstract][Full Text] [Related]
30. Anti-inflammatory effects of astroglial α7 nicotinic acetylcholine receptors are mediated by inhibition of the NF-κB pathway and activation of the Nrf2 pathway. Patel H; McIntire J; Ryan S; Dunah A; Loring R J Neuroinflammation; 2017 Sep; 14(1):192. PubMed ID: 28950908 [TBL] [Abstract][Full Text] [Related]
31. Deficits of synaptic functions in hippocampal slices prepared from aged mice null α7 nicotinic acetylcholine receptors. Ma L; Turner D; Zhang J; Wang Q; Wang M; Shen J; Zhang S; Wu J Neurosci Lett; 2014 Jun; 570():97-101. PubMed ID: 24769321 [TBL] [Abstract][Full Text] [Related]
32. Selective activation of α7 nicotinic acetylcholine receptors augments hippocampal oscillations. Stoiljkovic M; Kelley C; Nagy D; Leventhal L; Hajós M Neuropharmacology; 2016 Nov; 110(Pt A):102-108. PubMed ID: 27422408 [TBL] [Abstract][Full Text] [Related]
33. Hydrophobic residues at position 10 of α-conotoxin PnIA influence subtype selectivity between α7 and α3β2 neuronal nicotinic acetylcholine receptors. Hopping G; Wang CI; Hogg RC; Nevin ST; Lewis RJ; Adams DJ; Alewood PF Biochem Pharmacol; 2014 Oct; 91(4):534-42. PubMed ID: 25101833 [TBL] [Abstract][Full Text] [Related]
34. Concentration-response relationship of the α7 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays. Stoiljkovic M; Leventhal L; Chen A; Chen T; Driscoll R; Flood D; Hodgdon H; Hurst R; Nagy D; Piser T; Tang C; Townsend M; Tu Z; Bertrand D; Koenig G; Hajós M Biochem Pharmacol; 2015 Oct; 97(4):576-589. PubMed ID: 26206187 [TBL] [Abstract][Full Text] [Related]
35. [(125)I]Iodo-ASEM, a specific in vivo radioligand for α7-nAChR. Gao Y; Mease RC; Olson TT; Kellar KJ; Dannals RF; Pomper MG; Horti AG Nucl Med Biol; 2015 May; 42(5):488-493. PubMed ID: 25687449 [TBL] [Abstract][Full Text] [Related]
36. Evaluation of the Relationship Between Cognitive Impairment, Glycometabolism, and Nicotinic Acetylcholine Receptor Deficits in a Mouse Model of Alzheimer's Disease. Matsuura Y; Ueda M; Higaki Y; Sano K; Saji H; Enomoto S Mol Imaging Biol; 2019 Jun; 21(3):519-528. PubMed ID: 30047036 [TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of new imaging agent for central nicotinic acetylcholine receptor α7 subtype. Ogawa M; Nishiyama S; Tsukada H; Hatano K; Fuchigami T; Yamaguchi H; Matsushima Y; Ito K; Magata Y Nucl Med Biol; 2010 Apr; 37(3):347-55. PubMed ID: 20346874 [TBL] [Abstract][Full Text] [Related]
38. Genetic deletion of the adenosine A(2A) receptor prevents nicotine-induced upregulation of α7, but not α4β2* nicotinic acetylcholine receptor binding in the brain. Metaxas A; Al-Hasani R; Farshim P; Tubby K; Berwick A; Ledent C; Hourani S; Kitchen I; Bailey A Neuropharmacology; 2013 Aug; 71():228-36. PubMed ID: 23583933 [TBL] [Abstract][Full Text] [Related]
39. On the interaction of β-amyloid peptides and α7-nicotinic acetylcholine receptors in Alzheimer's disease. Oz M; Lorke DE; Yang KH; Petroianu G Curr Alzheimer Res; 2013 Jul; 10(6):618-30. PubMed ID: 23627750 [TBL] [Abstract][Full Text] [Related]
40. A Methyl Scan of the Pyrrolidinium Ring of Nicotine Reveals Significant Differences in Its Interactions with Xing H; Andrud KW; Soti F; Rouchaud A; Jahn SC; Lu Z; Cho YH; Habibi S; Corsino P; Slavov S; Rocca JR; Lindstrom JM; Lukas RJ; Kem WR Mol Pharmacol; 2020 Aug; 98(2):168-180. PubMed ID: 32474444 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]